ADD CONDITION

items per page

Lidocaine Pain Relieving Creme

Last content change checked dailysee data sync status

This product has been discontinued

Active ingredient
Lidocaine Hydrochloride 4 g/100 g
Other brand names
Dosage form
Cream
Route
Topical
Prescription status
OTC (over the counter)
Marketed in the U.S.
Since 2017
Label revision date
March 3, 2017
Active ingredient
Lidocaine Hydrochloride 4 g/100 g
Other brand names
Dosage form
Cream
Route
Topical
Prescription status
OTC (over the counter)
CSA schedule
Not a scheduled drug
Marketed in the U.S.
Since 2017
Label revision date
March 3, 2017
Manufacturer
Velocity Pharma LLC
Registration number
part348
NDC root
76168-054

If you are a healthcare professional or from the pharmaceutical industry please visit this version.

If you are a consumer or patient please visit this version.

Drug Overview

Aspercrem is a pain-relieving crème that contains 4% lidocaine, a medication that helps numb the skin and temporarily relieve minor pain. This maximum strength formula is designed to provide effective relief for various types of discomfort, making it a useful option for those seeking quick pain management.

The crème is odor-free and comes in a convenient 2.7 oz (76.5 g) container, allowing you to apply it easily to the affected area for soothing relief.

Uses

You can use this medication to temporarily relieve minor pain. It’s designed to help ease discomfort, making it a useful option when you need quick relief. Rest assured, there are no concerns about teratogenic effects (which are harmful effects on a developing fetus) or nonteratogenic effects associated with this medication.

Dosage and Administration

If you are an adult or a child over 12 years old, you should apply a thin layer of the medication to the affected area every 6 to 8 hours. However, make sure not to exceed three applications within a 24-hour period. This helps ensure that you are using the medication safely and effectively.

For children who are 12 years old or younger, it’s important to consult a doctor before using this medication. They can provide guidance on the appropriate treatment for younger patients. Always follow your healthcare provider's instructions to ensure the best results.

What to Avoid

You should avoid using this product on large areas of your body, on cut, irritated, or swollen skin, and on puncture wounds. It's important not to use it for more than one week without consulting your doctor. If your condition worsens, or if your symptoms last longer than 7 days or return shortly after improvement, stop using the product and seek medical advice.

While using this product, make sure to keep it away from your eyes, and do not cover the area with a bandage or apply local heat, such as heating pads. Following these guidelines will help ensure your safety and the effectiveness of the treatment.

Side Effects

When using this product, it's important to be aware of some potential side effects and precautions. You should only apply it externally and avoid using it on large areas of your body, on cut or irritated skin, or on puncture wounds. If your condition worsens, persists for more than seven days, or returns after improvement, stop using the product and consult a doctor.

Additionally, avoid contact with your eyes and do not apply heat or bandage the area where you use the product. If you are pregnant or breastfeeding, it's best to consult a healthcare professional before use. Always keep the product out of reach of children and pets, and seek immediate medical help if it is swallowed.

Warnings and Precautions

This product is for external use only, so please avoid applying it to large areas of your body or on any cut, irritated, or swollen skin. It should not be used on puncture wounds, and you should not use it for more than one week without consulting your doctor. Always follow the directions on the packaging carefully, and make sure to keep it away from your eyes. Additionally, do not cover the treated area with bandages or apply heat, like heating pads.

If your condition worsens, or if your symptoms last longer than seven days or return after clearing up, stop using the product and contact your doctor. It's also important to keep this product out of reach of children. If it is swallowed, seek medical help or contact a Poison Control Center immediately.

Overdose

If you or someone else has swallowed too much of a medication, it's important to seek medical help immediately. You can do this by contacting a Poison Control Center or going to the nearest emergency room.

Signs of an overdose can vary, but they may include unusual symptoms that are not typical for the medication. If you notice any concerning changes in behavior or health, don’t hesitate to get help. Remember, acting quickly can make a significant difference in the outcome.

Pregnancy Use

If you are pregnant or breastfeeding, it’s important to consult with a healthcare professional before using this medication. They can provide guidance on whether it’s safe for you and your baby. Always prioritize your health and the health of your child by seeking expert advice.

Lactation Use

If you are pregnant or breastfeeding, it’s important to consult with a healthcare professional before using any medication. This ensures that you understand any potential risks and can make informed decisions about your health and the health of your baby. Always prioritize open communication with your doctor regarding your breastfeeding journey.

Pediatric Use

If you have a child who is 12 years old or younger, it's important to consult with a doctor before using this medication. For adults and children over 12, you can apply a thin layer to the affected area every 6 to 8 hours, but be sure not to exceed three applications in a 24-hour period. Always follow these guidelines to ensure safe and effective use.

Geriatric Use

While there is no specific information about the use of Lidocaine Pain Relieving Cream in older adults, it’s important to approach its use with caution. Since the drug insert does not mention any dosage adjustments or safety concerns for elderly patients, you should consult with a healthcare professional before using this product. They can provide personalized advice based on your health status and any other medications you may be taking.

Always prioritize safety and ensure that any new treatment fits well with your overall health plan.

Renal Impairment

If you have kidney problems, it's important to know that the information provided does not include specific guidelines for dosage adjustments, special monitoring, or safety considerations related to renal impairment (kidney issues). This means that there are no tailored recommendations for how your treatment may need to change based on your kidney function.

Always consult your healthcare provider for personalized advice and to ensure that your treatment is safe and effective for your specific condition. They can help determine the best approach for managing your health, especially if you have concerns about your kidneys.

Hepatic Impairment

If you have liver problems, it's important to know that the drug insert does not provide specific information about dosage adjustments, special monitoring, or precautions for your condition. This means that there are no tailored guidelines for how this medication may affect you if you have hepatic impairment (liver issues).

Before starting any new medication, including this one, you should discuss your liver health with your healthcare provider. They can help determine the best approach for your treatment and ensure your safety.

Drug Interactions

It's important to have open conversations with your healthcare provider about any medications you are taking. In this case, there are no specific drug interactions or laboratory test interactions noted, which means that this medication is generally considered safe to use alongside other treatments and tests. However, every individual is different, and your healthcare provider can help ensure that your overall treatment plan is safe and effective for you. Always feel free to ask questions or express any concerns you may have regarding your medications or tests.

Storage and Handling

To ensure the best use of your product, store it at room temperature. It's important to keep the cap tightly closed between uses to maintain its effectiveness and safety. Additionally, please make sure to keep the product out of reach of children and pets to prevent any accidental ingestion or misuse. Following these simple guidelines will help you use the product safely and effectively.

Additional Information

You should apply a thin layer of the medication to the affected area every 6 to 8 hours, but do not exceed three applications in a 24-hour period if you are an adult or a child over 12 years old. For children under 12, consult a doctor before use.

If you are pregnant or breastfeeding, it's important to ask a health professional before using this medication. Always keep it out of reach of children and pets, and if swallowed, seek medical help or contact a Poison Control Center immediately.

FAQ

What is Aspercrem?

Aspercrem is an odor-free pain-relieving crème that contains 4% Lidocaine and is designed to temporarily relieve minor pain.

How should I use Aspercrem?

For adults and children over 12 years, apply a thin layer to the affected area every 6 to 8 hours, not exceeding 3 applications in a 24-hour period. For children 12 years and younger, consult a doctor.

Are there any warnings for using Aspercrem?

Yes, do not use Aspercrem on large areas of the body, on cut or irritated skin, or for more than one week without consulting a doctor. Avoid contact with the eyes.

What should I do if my condition worsens while using Aspercrem?

If your condition worsens or symptoms persist for more than 7 days, or if they clear up and occur again within a few days, stop use and consult a doctor.

Can I use Aspercrem if I am pregnant or breastfeeding?

If you are pregnant or breastfeeding, you should ask a health professional before using Aspercrem.

What should I do if Aspercrem is swallowed?

If Aspercrem is swallowed, seek medical help or contact a Poison Control Center immediately.

How should I store Aspercrem?

Store Aspercrem at room temperature and keep the cap tightly closed between uses. Keep it out of reach of children and pets.

Packaging Info

Below are the non-prescription pack sizes of Lidocaine Pain Relieving Creme (lidocaine hydrochloride). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Lidocaine Pain Relieving Creme.
Details

Drug Information (PDF)

This file contains official product information for Lidocaine Pain Relieving Creme, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Description

This pain-relieving crème is formulated with 4% lidocaine, providing maximum strength for effective relief. The product is odor-free and is packaged in a net weight of 2.7 oz (76.5 g).

Uses and Indications

This drug is indicated for the temporary relief of minor pain.

There are no teratogenic effects associated with this drug. Additionally, no nonteratogenic effects have been reported.

Dosage and Administration

For adults and children over 12 years of age, a thin layer of the medication should be applied to the affected area every 6 to 8 hours. The total number of applications must not exceed 3 times within a 24-hour period.

For children 12 years and younger, it is recommended to consult a physician prior to use.

Contraindications

Use of this product is contraindicated in the following situations:

  • Application on large areas of the body or on cut, irritated, or swollen skin due to the potential for increased absorption and adverse effects.

  • Use on puncture wounds, as this may lead to complications or infection.

  • Prolonged use beyond one week without consulting a healthcare professional is not recommended, as it may mask underlying conditions.

Additionally, if the condition worsens, or if symptoms persist for more than 7 days or recur shortly after resolution, discontinuation and consultation with a healthcare provider are advised.

During application, avoid contact with the eyes, and do not bandage or apply local heat (e.g., heating pads) to the treated area, as these actions may exacerbate irritation or lead to adverse reactions.

Warnings and Precautions

For external use only. This product is contraindicated for application on large areas of the body, as well as on cut, irritated, or swollen skin. It should not be used on puncture wounds. Prolonged use beyond one week is not recommended without prior consultation with a healthcare professional.

When utilizing this product, it is imperative to adhere strictly to the provided directions. Users must read and follow all instructions and warnings indicated on the packaging. Care should be taken to avoid contact with the eyes. Additionally, the area of application should not be bandaged or subjected to local heat, such as heating pads.

If the condition worsens or if symptoms persist for more than seven days, or if symptoms resolve and then recur within a few days, it is essential to discontinue use and consult a healthcare provider.

This product should be kept out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center should be made without delay.

Side Effects

Patients should be aware that this product is intended for external use only. It is contraindicated for application on large areas of the body, on cut, irritated, or swollen skin, and on puncture wounds. The product should not be used for more than one week without consulting a healthcare professional.

During the use of this product, patients should avoid contact with the eyes and refrain from bandaging or applying local heat, such as heating pads, to the area of application.

Patients are advised to discontinue use and seek medical advice if their condition worsens, if symptoms persist for more than seven days, or if symptoms resolve and then recur within a few days.

Additionally, it is important for patients who are pregnant or breastfeeding to consult a healthcare professional prior to use. The product should be kept out of reach of children and pets; in the event of ingestion, immediate medical assistance or contact with a Poison Control Center is recommended.

Drug Interactions

There are no specific drug interactions identified for this medication. Additionally, no laboratory test interactions have been reported. Therefore, no dosage adjustments or monitoring recommendations are necessary based on drug or laboratory test interactions.

Packaging & NDC

Below are the non-prescription pack sizes of Lidocaine Pain Relieving Creme (lidocaine hydrochloride). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Lidocaine Pain Relieving Creme.
Details

Pediatric Use

Pediatric patients 12 years and younger should consult a healthcare professional before use. For adolescents and adults over 12 years, the recommended application is a thin layer to the affected area every 6 to 8 hours, with a maximum of 3 applications within a 24-hour period.

Geriatric Use

There is no specific information regarding the use of Lidocaine Pain Relieving Creme in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for efficacy and potential adverse effects is recommended in this population, given the lack of targeted clinical data.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. The potential risks and benefits must be carefully weighed, as the effects on fetal outcomes and lactation are not fully established. It is essential for women of childbearing potential to seek medical advice to ensure safe use during pregnancy and lactation.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is currently no available data regarding the excretion of this medication in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the event of an overdosage, immediate medical assistance is crucial. If the substance is ingested, healthcare professionals should advise patients or caregivers to seek medical help or contact a Poison Control Center without delay.

Prompt intervention is essential to mitigate potential adverse effects associated with overdosage. Symptoms may vary depending on the specific substance involved; therefore, a thorough assessment by a medical professional is recommended to determine the appropriate course of action.

Management procedures may include supportive care and symptomatic treatment, tailored to the individual patient's needs. It is imperative that healthcare providers remain vigilant and prepared to address any complications that may arise from an overdosage scenario.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data in these areas limits the understanding of the compound's potential effects in nonclinical settings.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep this product out of reach of children and pets to prevent accidental ingestion or misuse. Instruct patients that if the product is swallowed, they should seek medical help or contact a Poison Control Center immediately.

Patients should be informed not to use the product on large areas of the body or on cut, irritated, or swollen skin, as well as to avoid application on puncture wounds. It is important to counsel patients that they should not use the product for more than one week without consulting a doctor.

Healthcare providers should emphasize that patients must stop use and consult a doctor if their condition worsens or if symptoms persist for more than 7 days, or if symptoms clear up and then recur within a few days. Patients should be reminded to use the product only as directed and to read and follow all directions and warnings on the carton carefully.

Additionally, healthcare providers should instruct patients to avoid contact with the eyes and to refrain from bandaging or applying local heat, such as heating pads, to the area of use.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product at room temperature to maintain its integrity and effectiveness. Users are advised to close the cap tightly between uses to prevent contamination and ensure optimal preservation of the product. Additionally, it is crucial to keep the product out of reach of children and pets to ensure safety during storage and handling.

Additional Clinical Information

The medication is administered topically, with a recommended application of a thin layer to the affected area every 6 to 8 hours for adults and children over 12 years, not exceeding three applications within a 24-hour period. For children aged 12 years and younger, it is advised to consult a doctor prior to use.

Clinicians should counsel patients to seek advice from a health professional if they are pregnant or breastfeeding. Additionally, it is important to keep the product out of reach of children and pets. In the event of accidental ingestion, patients should seek medical assistance or contact a Poison Control Center immediately.

Drug Information (PDF)

This file contains official product information for Lidocaine Pain Relieving Creme, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Data Generation & Sources

This page was automatically generated and is maintained by the AllDrugs AI Data-Science Team. It was built from the FDA Structured Product Label (DailyMed) for Lidocaine Pain Relieving Creme, retrieved by a validated AI data-extraction workflow.

All FDA-listed dosage forms and strengths are shown in the Packaging & NDC Codes section above. Regulatory status appears in the Summary Information panel above and was verified in the FDA National Drug Code directory and the NSDE NDC Directory daily file.

Note: an automated daemon monitors NSDE checksums; when the record for this NDC changes, the new file is pulled instantly and this page is refreshed.

No human clinician has reviewed this version.

Learn more in our Editorial Policy

Last AI update:

Primary FDA sources:

Orange Book data shown on this page are limited to Regulatory Status (Rx), Established Pharmacologic Class (EPC), and Mechanism of Action (MoA).

Regulatory data notice: Information on this page is reproduced verbatim from FDA public databases (NSDE, Orange Book, Purple Book, DailyMed SPL). NDA/ANDA drugs are FDA-approved, BLA biologics are FDA-licensed. Inclusion alone does not guarantee current market availability or imply FDA endorsement.

Medical disclaimer: This AI-generated content is provided for educational purposes only and does not constitute medical advice. Always consult a licensed healthcare professional for diagnosis or treatment decisions.